{"nct_id":"NCT03834662","title":"A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients Malignancies","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2019-01-07","start_date_type":"ACTUAL","primary_completion_date":"2020-02-19","primary_completion_date_type":"ACTUAL","completion_date":"2020-02-19","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BMY"]}